glp-1 and migraines Drug Cuts Migraine Days in Half A new study finds that the diabetes drug liraglutide significantly reduced monthly migraine days in patients with obesity chronic migraine. Participants reported an average Has anyone tried GLP1 for

Documentation of Harm: Evidence of the financial and personal impact of the injury, including medical bills, pay stubs, and personal journals detailing the daily effects of the condition

2023;22(4): doi:10.36849/JDD.6550 Citation: Ouellette S, Frias G, Shah R, et al

Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor

The long-acting analoguesparticularly semaglutide and tirzepatideachieve the greatest reductions in glycated hemoglobin and body weight, while liraglutide and dulaglutide show moderate but clinically relevant benefits

Since its still being studied, there arent any official prescribing guidelines yet

One teaspoon in a small cup creates very sweet water